Table 2.
Comparing paper level characteristics of published covid-19 and non-covid research
| COVID-19 papers n = 54 |
Non COVID papers n = 114 |
|
|---|---|---|
| Method,n(%) | ||
| Randomised controlled trial | 6 (11%) | 60 (53%) |
| Observational | 46 (85%) | 37 (32%) |
| Systematic reviews | 1 (2%) | 11 (10%) |
| Test accuracy | 0 (0%) | 4 (4%) |
| Other | 1 (2%) | 2 (2%) |
| Content median (IQR) | ||
| Total number included | 96 (16.5 to 762) | 815 (219 to 4893)* |
| Follow-up (weeks) | 4 (3 to 7) | 52 (28 to 116)* |
| Positive result, n (%) | 7 (13%) | 74 (65%)* |
| Industry funding, n (%) | 2 (4%) | 31 (27%)* |
| Post-publication,n(%) | ||
| Brief report format | 16 (30%) | 6 (5%)* |
| Editorial | 31 (57%) | 43 (38%)** |
| Correction/retraction | 7 (13%) | 0 (0%)* |
*Difference p < 0.0001
**Difference p < 0.05